跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANFUZOSIN MODIFIED RELEASE TABLETS 10MG - HSA Drug Approval Details
Approvals
/
HSA
/
RANFUZOSIN MODIFIED RELEASE TABLETS 10MG
Approved
THERAPEUTIC
RANFUZOSIN MODIFIED RELEASE TABLETS 10MG
SUN PHARMACEUTICAL INDUSTRIES LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Jul 5, 2011
Approval ID
4da8a34868152b8d
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Type
Therapeutic
Approval Details
Approval Id
4da8a34868152b8d
Drug Name
RANFUZOSIN MODIFIED RELEASE TABLETS 10MG
Product Name
RANFUZOSIN MODIFIED RELEASE TABLETS 10MG
Approval Number
SIN13984P
Approval Date
2011-07-05
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
G04CA01
Atc Item Name
alfuzosin
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
ALFUZOSIN HYDROCHLORIDE
10mg
ALFUZOSIN HYDROCHLORIDE
10 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 5, 2011
Approval ID
4da8a34868152b8d
Type
Therapeutic
Back to HSA Approvals